Chunying Shu Selected Research

fullerene C70

8/2020	Fullerene nanoparticles: a promising candidate for the alleviation of silicosis-associated pulmonary inflammation.
10/2016	Fullerene/photosensitizer nanovesicles as highly efficient and clearable phototheranostics with enhanced tumor accumulation for cancer therapy.
2/2015	Amphiphilic trismethylpyridylporphyrin-fullerene (C70) dyad: an efficient photosensitizer under hypoxia conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunying Shu Research Topics

Disease

17	Neoplasms (Cancer) 01/2021 - 04/2010
3	Inflammation (Inflammations) 08/2020 - 01/2018
2	Necrosis 01/2018 - 07/2012
1	Chronic Renal Insufficiency 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Silicosis 08/2020
1	Lung Injury 08/2020
1	Pneumonia (Pneumonitis) 08/2020
1	Occupational Diseases (Occupational Disease) 08/2020
1	Radiation Injuries (Radiation Sickness) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 06/2019
1	Bacterial Infections (Bacterial Infection) 04/2019
1	Wound Infection (Wound Infections) 04/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Hyperglycemia 01/2019
1	Insulin Resistance 01/2019
1	Cardiotoxicity 11/2018
1	Wounds and Injuries (Trauma) 11/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Acute Lung Injury 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Hypoxia (Hypoxemia) 02/2015
1	Pathologic Processes 04/2014
1	Lung Neoplasms (Lung Cancer) 10/2013
1	AIDS-Related Complex (ARC) 08/2009

Drug/Important Bio-Agent (IBA)

8	FullerenesIBA 01/2021 - 08/2009
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 10/2017
6	gadofullereneIBA 01/2020 - 01/2017
4	Photosensitizing Agents (Photosensitizers)IBA 10/2016 - 07/2012
3	fullerene C70IBA 08/2020 - 02/2015
3	Alanine (L-Alanine)FDA Link 08/2020 - 01/2017
3	AminesIBA 06/2019 - 09/2015
2	CarbonIBA 01/2019 - 01/2016
2	Oxygen (Dioxygen)IBA 01/2019 - 02/2015
2	Amino Acids FDA Link 11/2018 - 01/2017
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2015 - 10/2013
1	Biological ProductsIBA 01/2021
1	Hydroxyl RadicalIBA 08/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 08/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2019
1	IsotopesIBA 06/2019
1	triazacyclononaneIBA 06/2019
1	LigandsIBA 06/2019
1	AcidsIBA 06/2019
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 06/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	MetalloproteinsIBA 01/2019
1	EnzymesIBA 11/2018
1	fullerenolIBA 01/2018
1	Nanoparticle Drug Delivery SystemIBA 01/2018
1	cadherin 5IBA 01/2018
1	AntioxidantsIBA 01/2018
1	CollagenIBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	Therapeutic UsesIBA 01/2017
1	SolutionsIBA 11/2016
1	Human Serum Albumin FDA LinkGeneric 11/2016
1	gadoteridol (Prohance)FDA Link 11/2016
1	phytochlorinIBA 10/2016
1	malonic acid (malonate)IBA 10/2016
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2016
1	GadoliniumIBA 01/2016
1	GraphiteIBA 01/2016
1	monomethoxypolyethylene glycol (MPEG)IBA 09/2015
1	LutetiumIBA 09/2015
1	Singlet OxygenIBA 02/2015
1	PorphyrinsIBA 02/2015
1	Heme (Haem)IBA 04/2014
1	MicellesIBA 02/2013
1	IonsIBA 04/2010
1	GD3 ganglioside (GD(3))IBA 04/2010

Therapy/Procedure

10	Therapeutics 01/2021 - 02/2013
3	Drug Therapy (Chemotherapy) 11/2018 - 08/2014
3	Precision Medicine 10/2016 - 09/2015
3	Photochemotherapy (Photodynamic Therapy) 10/2016 - 02/2015
1	Radiotherapy 01/2020
1	Lasers (Laser) 02/2013
1	Brachytherapy 04/2010